tradingkey.logo
tradingkey.logo
検索

Aytu Biopharma Inc

AYTU
ウォッチリストに追加
2.160USD
+0.010+0.47%
終値 07/01, 16:00ET15分遅れの株価
23.18M時価総額
損失額直近12ヶ月PER

詳細情報 Aytu Biopharma Inc 企業名

Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.

Aytu Biopharma Incの企業情報

企業コードAYTU
会社名Aytu Biopharma Inc
上場日Oct 20, 2017
最高経営責任者「CEO」Disbrow (Joshua R)
従業員数82
証券種類Ordinary Share
決算期末Oct 20
本社所在地7900 E. Union Avenue
都市DENVER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号80237
電話番号17204376580
ウェブサイトhttps://aytubio.com/
企業コードAYTU
上場日Oct 20, 2017
最高経営責任者「CEO」Disbrow (Joshua R)

Aytu Biopharma Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

よくある質問

Aytu Biopharma Incの上位5名の株主は誰ですか?

Aytu Biopharma Incの上位5名の株主は以下のとおりです。Mr. Jarrett T. (Josh) Disbrow

Aytu Biopharma Inc(AYTU)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Aytu Biopharma Incの株式を保有している機関は69社あり、保有株式の総市場価値は約3.87Mで、全体の36.10%を占めています。2025Q4と比較して、機関の持ち株は-493525.00増加しています。

Aytu Biopharma Incの最大の収益源は何ですか?

2026Q1において、ADHD portfolio部門がAytu Biopharma Incにとって最大の収益を生み出しており、その金額は13.22Mで、全収益の87.15%を占めています。